Fresenius Requests Stay In Dialysis MDL To Ink Settlement
Fresenius Medical Care and plaintiffs with whom they reached a $250 million settlement in principle to end multidistrict litigation over the alleged side effects of the dialysis drugs GranuFlo and NaturaLyte...To view the full article, register now.
Already a subscriber? Click here to view full article